‹ ACAD latest research

ACAD (ACADIA Pharmaceuticals Inc.): every AI call and what happened next

TradeFlare's AI research teams analysed ACAD on 8 market nights between August 6, 2026 and September 15, 2026. Each row is that night's verdict, the price that day, and how the price actually moved afterwards — wins and misses alike. Nothing is edited after the fact.

8 calls 4 BUY · 4 HOLD · 0 SELL BUY calls up after 20 trading days: 0 of 4
DateVerdictPriceTarget / stop5 days later20 days laterWhy (that night)
September 15, 2026 HOLD $27.52 — / — -1.3% -30.4%
The setup does not meet the minimum R/R requirements for a trade.
September 9, 2026 HOLD $27.58 — / — -0.5% -29.0%
The current market and stock-specific technicals do not support a buy decision at this time.
September 8, 2026 HOLD $28.02 — / — -3.0% -28.4%
The current setup does not warrant a BUY.
September 7, 2026 BUY $28.02 $30.25 / $23.38 -3.0% -28.4%
The scanner trigger is an RSI pullback, suggesting a short-term mean-reversion opportunity.
September 4, 2026 HOLD $27.86 — / — -1.8% -28.2%
The current market and stock setup does not warrant a buy.
August 11, 2026 BUY $29.21 $34.20 / $24.23 +2.6% -5.9%
The post-earnings drift signal suggests a multi-week opportunity.
August 10, 2026 BUY $29.21 $34.20 / $24.23 -1.3% -6.2%
The post-earnings drift signal suggests a multi-week opportunity.
August 6, 2026 BUY $28.80 $34.56 / $24.48 -0.2% -2.1%
The stock is breaking out to new highs with strong momentum, suggesting a multi-week trend.

Prices are daily closes. "Days later" counts trading days from the close on the day of the call. A HOLD is not a recommendation to buy; only published signals are tracked with a target and stop on the public record. How the research works. Updated October 14, 2026. AI-generated research for educational purposes — it can be wrong and is not financial advice.